Donanemab: The Breakthrough Drug Ushering a New Era in Alzheimer’s Treatment
A new Alzheimer's drug, Donanemab shows a 35% slowdown in cognitive decline.
A new Alzheimer's drug, Donanemab shows a 35% slowdown in cognitive decline.
Wearing hearing aides can slow the rate of decline in certain populations
At this year's Alzheimer’s Association International Conference, it was announced [...]
Neuroscience News Reveals: Mental Acuity Tasks Outshine Socializing in Mitigating [...]
Medical teams are preparing to begin offering Lecanemab with FDA [...]
Neuroscience News reports "Stress may be a factor in why [...]
Science Daily recently writes "A world-first trial at UCL and [...]
"A new study from a team led by researchers at [...]
NeuroscienceNews writes "Using machine learning technology, researchers concluded the risk [...]
NBC Reports "A diet that is rich in seafood, fruit, [...]